Literature DB >> 23986431

Nummular headache after trans-sphenoidal surgery: a referred pain-based headache syndrome.

H-L Yin1, Chi Chui, W-F Tung, W-H Chen.   

Abstract

Nummular headache (NH) is a newly categorized primary headache characterized by a consistent location, shape and size of painful area in each attack. The etiopathogenesis is entirely unknown. Currently, the peripheral theory of epicranial neuralgia is accepted more widely than the central theory but it cannot fully explain the clinical picture. We report a patient who suffered from a relapsing and remitting course of NH at the high parietal area and vertex shortly after resection for pituitary prolactinoma via a trans-sphenoidal approach. There was no focal trophic change or paresthesia but a mild allodynia in the painful area. The patient did not exhibit trigeminal sensory disorder or cranial trauma thoroughly. The pain responded well to gabapentin. Therefore, physicians should be aware of postoperative NH, which is amenable to treatment. The findings in our patient support a dual mechanism of NH and suggest that central NH is a form of referred pain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986431     DOI: 10.5114/ninp.2013.36764

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  3 in total

Review 1.  Nummular Headache.

Authors:  Danielle Wilhour; Claire E J Ceriani; Stephanie J Nahas
Journal:  Curr Neurol Neurosci Rep       Date:  2019-04-17       Impact factor: 5.081

2.  Nummular headache and pituitary lesion: A case report and literature review.

Authors:  Chi Chui; Wei Hsi Chen; Hsin Ling Yin
Journal:  Ann Indian Acad Neurol       Date:  2013-04       Impact factor: 1.383

3.  Characteristics and treatment effectiveness of the nummular headache: a systematic review and analysis of 110 cases.

Authors:  Urvish K Patel; Sidra Saleem; Arsalan Anwar; Preeti Malik; Bindi Chauhan; Ashish Kapoor; Kogulavadanan Arumaithurai; Tapan Kavi
Journal:  BMJ Neurol Open       Date:  2020-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.